Transplantation surgeon, founder and CEO of Polbionica
Michał Wszoła MD, PhD – transplantation surgeon, devoted doctor and a visionary scientist, creator of bionic pancreas – an organ that will reintroduce the ability of the body to regulate the blood sugar level and revolutionize diabetes treatment. Founder and CEO of Polbionica – a Polish start-up established in August 2019 by the Foundation on Research and Science Development in order to commercialize research of bioprinting 3D bionic pancreas.
Development of bioprinting technology of 3D bionic pancreas poses a real chance for breakthrough in the type I diabetes treatment for patients all over the world. Implementation of this innovative therapy in clinical practice will be one of the greatest successes of medicine in the 21st century. Having in mind growing number of patients and limitations of currently applied methods, the bionic pancreas will help to solve the problem of lack of organs for transplantation as well as complications connected with surgery and long-term immunosuppression following the transplantation procedure. Currently, the team of Polbionica in cooperation with key Polish scientific centers, continues research on bionic pancreas and introduces to market crucial innovative products supporting the development of 3D bioprinting of organs needed for transplantation.
Polbionica is in the process of conceptual and organizational works aimed at establishing the European Center of Medical Biotechnology – a highly innovative, multidisciplinary research and implementation center in the field of life science. By integrating and consolidating the scientific and technological potential of the consortium members, it will be possible to carry out all phases of scientific research, up to commercialization of the developed solutions and products on a global scale.